![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PPP1R16A |
Gene summary for PPP1R16A |
![]() |
Gene information | Species | Human | Gene symbol | PPP1R16A | Gene ID | 84988 |
Gene name | protein phosphatase 1 regulatory subunit 16A | |
Gene Alias | MYPT3 | |
Cytomap | 8q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | Q96I34 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84988 | PPP1R16A | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.74e-02 | 3.48e-01 | -0.1808 |
84988 | PPP1R16A | HTA11_347_2000001011 | Human | Colorectum | AD | 1.36e-10 | 4.41e-01 | -0.1954 |
84988 | PPP1R16A | HTA11_696_2000001011 | Human | Colorectum | AD | 2.62e-04 | 3.14e-01 | -0.1464 |
84988 | PPP1R16A | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.91e-06 | 4.97e-01 | -0.059 |
84988 | PPP1R16A | HTA11_99999971662_82457 | Human | Colorectum | MSS | 7.58e-16 | 5.94e-01 | 0.3859 |
84988 | PPP1R16A | A002-C-205 | Human | Colorectum | FAP | 2.50e-05 | -1.76e-01 | -0.1236 |
84988 | PPP1R16A | A015-C-006 | Human | Colorectum | FAP | 7.60e-03 | 9.98e-02 | -0.0994 |
84988 | PPP1R16A | A002-C-114 | Human | Colorectum | FAP | 1.37e-03 | -9.59e-02 | -0.1561 |
84988 | PPP1R16A | A002-C-116 | Human | Colorectum | FAP | 6.93e-05 | -2.53e-01 | -0.0452 |
84988 | PPP1R16A | A018-E-020 | Human | Colorectum | FAP | 4.18e-03 | -2.18e-02 | -0.2034 |
84988 | PPP1R16A | CRC-3-11773 | Human | Colorectum | CRC | 1.38e-04 | 3.69e-01 | 0.2564 |
84988 | PPP1R16A | LZE4T | Human | Esophagus | ESCC | 8.56e-14 | 5.21e-01 | 0.0811 |
84988 | PPP1R16A | LZE7T | Human | Esophagus | ESCC | 1.45e-02 | 9.69e-02 | 0.0667 |
84988 | PPP1R16A | LZE20T | Human | Esophagus | ESCC | 3.23e-09 | 3.38e-01 | 0.0662 |
84988 | PPP1R16A | LZE22D1 | Human | Esophagus | HGIN | 4.30e-04 | 1.75e-01 | 0.0595 |
84988 | PPP1R16A | LZE24T | Human | Esophagus | ESCC | 7.45e-09 | 3.10e-01 | 0.0596 |
84988 | PPP1R16A | LZE22D3 | Human | Esophagus | HGIN | 4.26e-02 | 3.24e-01 | 0.0653 |
84988 | PPP1R16A | P1T-E | Human | Esophagus | ESCC | 1.25e-13 | 5.81e-01 | 0.0875 |
84988 | PPP1R16A | P2T-E | Human | Esophagus | ESCC | 4.93e-22 | 4.06e-01 | 0.1177 |
84988 | PPP1R16A | P4T-E | Human | Esophagus | ESCC | 4.97e-13 | 1.99e-01 | 0.1323 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0035303113 | Thyroid | ATC | regulation of dephosphorylation | 70/6293 | 128/18723 | 7.24e-07 | 9.65e-06 | 70 |
GO:0006470111 | Thyroid | ATC | protein dephosphorylation | 129/6293 | 281/18723 | 1.11e-05 | 1.09e-04 | 129 |
GO:001631117 | Thyroid | ATC | dephosphorylation | 179/6293 | 417/18723 | 3.88e-05 | 3.15e-04 | 179 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PPP1R16A | SNV | Missense_Mutation | c.1330N>G | p.Pro444Ala | p.P444A | Q96I34 | protein_coding | tolerated(0.27) | benign(0) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
PPP1R16A | SNV | Missense_Mutation | rs559264971 | c.1262G>A | p.Arg421Gln | p.R421Q | Q96I34 | protein_coding | tolerated(0.29) | benign(0.022) | TCGA-AZ-4615-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | xeloda | PD |
PPP1R16A | SNV | Missense_Mutation | c.1235N>G | p.Asn412Ser | p.N412S | Q96I34 | protein_coding | tolerated(0.24) | benign(0.021) | TCGA-D5-6529-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | oxaliplatinum+ | SD | |
PPP1R16A | SNV | Missense_Mutation | novel | c.1367N>C | p.Leu456Pro | p.L456P | Q96I34 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-G4-6314-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Ancillary | leucovorin | SD |
PPP1R16A | deletion | Frame_Shift_Del | rs777096925 | c.1328delN | p.His445ThrfsTer15 | p.H445Tfs*15 | Q96I34 | protein_coding | TCGA-AY-6197-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
PPP1R16A | deletion | Frame_Shift_Del | rs777096925 | c.1328delN | p.His445ThrfsTer15 | p.H445Tfs*15 | Q96I34 | protein_coding | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD | ||
PPP1R16A | SNV | Missense_Mutation | novel | c.260T>C | p.Val87Ala | p.V87A | Q96I34 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PPP1R16A | SNV | Missense_Mutation | novel | c.601N>A | p.Glu201Lys | p.E201K | Q96I34 | protein_coding | deleterious(0.04) | possibly_damaging(0.788) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PPP1R16A | SNV | Missense_Mutation | rs759928158 | c.1507N>A | p.Gly503Arg | p.G503R | Q96I34 | protein_coding | deleterious(0.01) | possibly_damaging(0.486) | TCGA-D1-A3DA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | CR |
PPP1R16A | SNV | Missense_Mutation | rs754557567 | c.629N>A | p.Arg210His | p.R210H | Q96I34 | protein_coding | tolerated(0.55) | benign(0.009) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |